Jason Zemansky Stock Analyst Profile - B of A Securities Research Coverage - Stocknear

Jason Zemansky

Stock Analyst at B of A Securities

(4.96)
# 543
Out of 5,506 analysts
49
Total ratings
Success rate
Average return

14 Stocks

Name Action PT Current % Upside Ratings Updated
CYTK Cytokinetics
Maintains: Neutral
52 56
56.97 -1.7% 5 Oct 2, 2025
HOWL Werewolf Therapeutic...
Maintains: Buy
9 8
2.05 290.24% 5 Aug 25, 2025
RCKT Rocket Pharmaceutica...
Upgrades: Buy
4 10
3.15 217.46% 2 Aug 20, 2025
INSM Insmed
Maintains: Strong Buy
94 109
157.16 -30.64% 10 Jun 11, 2025
KROS Keros Therapeutics
Downgrades: Neutral
32 18
15.94 12.92% 2 Jun 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 31
24.64 25.81% 4 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
22 17
13.36 27.25% 5 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 29
9.57 203.03% 2 Nov 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
30 31
15.6 98.72% 3 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
3 3
3.3 -24.24% 5 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
391 23
n/a n/a 2 Dec 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
230
n/a n/a 1 Jul 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
450 162
n/a n/a 1 Feb 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
145 155
n/a n/a 2 Dec 13, 2021